Zobrazeno 1 - 10
of 83
pro vyhledávání: '"J. Rushakoff"'
Publikováno v:
Cancers, Vol 16, Iss 9, p 1663 (2024)
Immune checkpoint inhibitor (CPI)-induced diabetes mellitus (CPI-DM) is a rare immune-related adverse event (irAE). Patients and providers fear that continuing CPIs puts patients at risk for additional irAEs and thus may discontinue therapy. Currentl
Externí odkaz:
https://doaj.org/article/48de4719193a43e49c6f73d6480f9d4a
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/d8f5fcaacaea4c3cb3497c740752f985
Autor:
Andrew Folick, MD, PhD, Cheng Cheng, MD, Simon N. Chu, MD, Jonathan W. Rick, MD, Robert J. Rushakoff, MD, MS
Publikováno v:
AACE Clinical Case Reports, Vol 8, Iss 3, Pp 139-141 (2022)
Background: Oral hypoglycemic agents are a frequent cause of hypoglycemia in nondiabetic people. Here, we report a case of recurrent hypoglycemia caused by glipizide, in which diagnosis was delayed because of a combination of delayed hypoglycemic age
Externí odkaz:
https://doaj.org/article/ac4898a121694d39abb656d1fd3fe8b0
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)
Introduction To evaluate whether outpatient insulin treatment, hemoglobin A1c (HbA1c), glucose on admission, or glycemic control during hospitalization is associated with SARS-CoV-2 (COVID-19) illness severity or mortality in hospitalized patients wi
Externí odkaz:
https://doaj.org/article/3c36be452f63443b9e40a87fbfa0ea29
Autor:
Jingtong Huang, Andrea M. Yeung, Kevin T. Nguyen, Nicole Y. Xu, Jean-Charles Preiser, Robert J. Rushakoff, Jane Jeffrie Seley, Guillermo E. Umpierrez, Amisha Wallia, Andjela T. Drincic, Roma Gianchandani, M. Cecilia Lansang, Umesh Masharani, Nestoras Mathioudakis, Francisco J. Pasquel, Signe Schmidt, Viral N. Shah, Elias K. Spanakis, Andreas Stuhr, Gerlies M. Treiber, David C. Klonoff
Publikováno v:
Journal of diabetes science and technology. 16(5)
The annual Virtual Hospital Diabetes Meeting was hosted by Diabetes Technology Society on April 1 and April 2, 2022. This meeting brought together experts in diabetes technology to discuss various new developments in the field of managing diabetes in
Publikováno v:
AACE Clinical Case Reports, Vol 6, Iss 2, Pp e98-e100 (2020)
ABSTRACT: Objective: To increase awareness of unusual inflammatory and other responses including severe insulin resistance (IR) associated with the use of targeted immunotherapies such as brentuximab. Methods: We report the case of a man without any
Externí odkaz:
https://doaj.org/article/f86c961fd1b14a029f74cd85de1a7fdb
Publikováno v:
Endocrine Practice. 28:884-888
To identify clinical characteristics and factors associated with the development of euglycemic diabetic ketoacidosis (eDKA), and develop suitable strategies to reduce such events.Electronic health record (EHR) data were extracted to identify all pati
Autor:
Mary T Korytkowski, Ranganath Muniyappa, Kellie Antinori-Lent, Amy C Donihi, Andjela T Drincic, Irl B Hirsch, Anton Luger, Marie E McDonnell, M Hassan Murad, Craig Nielsen, Claire Pegg, Robert J Rushakoff, Nancy Santesso, Guillermo E Umpierrez
Publikováno v:
J Clin Endocrinol Metab
BackgroundAdult patients with diabetes or newly recognized hyperglycemia account for over 30% of noncritically ill hospitalized patients. These patients are at increased risk for adverse clinical outcomes in the absence of defined approaches to glyce
Publikováno v:
The Journal of Heart and Lung Transplantation. 42:S459
Autor:
G. Coutance, R. Jain, X. Zhang, L. Gragert, N. Patel, J. Patel, E. Kransdorf, J. Rushakoff, J. Kobashigawa
Publikováno v:
The Journal of Heart and Lung Transplantation. 42:S55